Elabscience E-EL-E606 SARS-CoV-2 Neutralization Antibody ELISA Kit User Manual

This test kit applies to the in vitro qualitative determination of Neutralization antibodies against SARS-CoV-2 in human serum or plasma.


Elabscience E-EL-E606 SARS-CoV-2 Neutralization Antibody ELISA Kit User Manual - cover page
Brand
Elabscience
Category
Health Care
Document type
User Manual
Language
English
Pages
9
File format
PDF
File size
642 KB
Published
18 October, 2023
Updated
18 October, 2023
MD5 checksum
3E9A61A3B783D16939741A7B2A291946

About this manual

This manual provides step-by-step instructions for using the Elabscience E-EL-E606 ELISA kit to detect SARS-CoV-2 neutralizing antibodies in human serum or plasma. It includes details on reagent preparation, assay protocol, washing steps, substrate addition, and optical density measurement. The kit uses a competitive ELISA method with pre-coated recombinant human ACE2 and HRP-conjugated RBD fragment. Results are interpreted based on inhibition percentage calculated from OD values of samples versus negative and positive controls.

The manual also outlines storage conditions for all components, sample collection and handling protocols, and quality control requirements, including acceptable OD ranges for positive and negative controls to validate test results.

What's inside

  • Intended Use
  • Test Principle
  • Kit Components & Storage
  • Sample Collection
  • Reagent Preparation
  • Pipetting Protocol
  • Assay Procedure
  • Quality Control
  • Interpretation
  • Analytical Performance

Specifications

Catalog NumberE-EL-E606
Product Size24T/96T/96T*5
Storage Temperature (Unopened)2-8℃
RepeatabilityCV ≤ 15%
Cut-off Value< 20%

Frequently asked questions

What is the purpose of this ELISA kit?

This ELISA kit is for in vitro qualitative determination of neutralization antibodies against SARS-CoV-2 in human serum or plasma.

How is the test performed?

The test uses a competitive ELISA method where SARS-CoV-2 neutralizing antibodies in samples compete with fixed human ACE2 for binding sites on HRP-conjugated RBD fragment.

What are the acceptable OD values for controls?

The OD of Negative Control must be greater than 1.2 and OD of Positive Control must be less than 0.4 for valid results.

How is the result interpreted?

Inhibition ≥ 20% indicates positive (neutralizing antibodies detected), and inhibition < 20% indicates negative (no neutralizing antibodies detected).

Download PDF (642 KB)

More Elabscience Manuals


View all Elabscience manuals →